IL-16 anti-HIV-1 therapyGregory A. Viglianti, William W. Cruikshank, Nereida A. Parada et al.|Nature Medicine|1997Cited by 12
A Lipidated Anti-Tat Antibody Enters Living Cells and Blocks HIV-1 Viral ReplicationWilliam W. Cruikshank, Bernard Malfroy, Susan R. Doctrow et al.|Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology|1997Cited by 10
Measurement of Interleukin 16William W. Cruikshank, Peter F. Weller, Nereida A. Parada et al.|Current Protocols in Immunology|1997Cited by 4
Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTRGregory A. Viglianti, Timothy M. Hanley|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2